<DOC>
<DOCNO>EP-0624596</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Tetrazole derivatives of bile acids, a process for their production and their use as medicines
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P300	A61P910	C07J900	A61P900	A61K31675	A61K31675	C07J4300	C07J4300	A61K3158	A61K31575	A61P306	A61K3158	A61K31575	C07J1700	C07J1700	C07J4100	C07J900	C07J4100	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	A61P	C07J	A61P	A61K	A61K	C07J	C07J	A61K	A61K	A61P	A61K	A61K	C07J	C07J	C07J	C07J	C07J	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P3	A61P9	C07J9	A61P9	A61K31	A61K31	C07J43	C07J43	A61K31	A61K31	A61P3	A61K31	A61K31	C07J17	C07J17	C07J41	C07J9	C07J41	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Tetrazole bile acid derivatives of the formula I  G1 - X - G2      I in which G1, G2 and X have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AG
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
ENHSEN ALFONS DR
</INVENTOR-NAME>
<INVENTOR-NAME>
GLOMBIK HEINER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KRAMER WERNER DR DR
</INVENTOR-NAME>
<INVENTOR-NAME>
WESS GUENTER DR
</INVENTOR-NAME>
<INVENTOR-NAME>
ENHSEN, ALFONS, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
GLOMBIK, HEINER, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
KRAMER, WERNER, DR.DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
WESS, GUENTER, DR.
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A tetrazole-bile acid derivative of the formula
I


G1 - X - G2

in which

G1
is H or a radical of the formula II


in which

R(1)
is H, an alkyl radical or alkenyl radical having up
to 10 carbon atoms, which is branched or unbranched,

a cycloalkyl radical having 3 to 8 carbon atoms,

a benzyl radical, which is unsubstituted or mono- to
trisubstituted by F, Cl, Br, (C
1
-C
4
)-alkyl or (C
1
C
4
)-
alkoxy,

a diphenylmethyl radical, which is unsubstituted or
mono- to trisubstituted by F, Cl, Br, (C
1
-C
4
)-alkyl
or (C
1
-C
4
)-alkoxy, a triphenylmethyl radical, which
is unsubstituted or mono- to trisubstituted by F,

Cl, Br, (C
1
-C
4
) -alkyl or (C
1
-C
4
)-alkoxy,

a C
1
-C
4
-alkoxymethyl or a tetrahydroxylamyl radical,
or a radical 



in which L is H, an alkyl radical or alkenyl radical
having up to 10 carbon atoms, which is branched or

unbranched, a cycloalkyl radical having 3 to 8
carbon atoms, a phenyl radical, which is unsubstituted

or mono- to trisubstituted by F, Cl, Br, (C
1
-C
4
)-alkyl,
(C
1
-C
4
)-alkoxy, or a benzyl radical,
which is unsubstituted or mono- to trisubstituted by

F, Cl, Br, (C
1
-C
4
)-alkyl or (C
1
-C
4
)-alkoxy,
R(2) to R(5),
where R(2) and R(3) or R(4) and R(5) in
each case together are the oxygen of a carbonyl

group, or individually and in each case independently
of one another are H, -OL, -SL, -NHL, tetrahydropyranyloxy

or C
1
-C
4
-alkoxymethoxy, in which L
has the abovementioned meaning, and
G2
is a radical of the formula IV


in which Z is

 
where m = zero to 4, n = zero or 1 and o = zero to

4,

V
is


-N-, -CH
2
-, -CH
2
CH
2
-
W
is H or, if V is -CH
2
- or -CH
2
CH
2
-, also OH
and R(6) to R(9) have the meaning given under R(2)

to R(5) and
X
is a bridge group or a covalent bond, and in which
G1 and G2 can be bonded via X as desired.
A tetrazole-bile acid derivative of the formula
I


G1 - X - G2

in which

G1
is H or a radical of the formula II


in which

R(1)
is H, formyl, acetyl, benzoyl, methoxymethyl or
tetrahydropyranyl,
R(2) to R(5),
where R(2) and R(3) or R(4) and R(5) in
each case together are the oxygen of a carbonyl

group, or individually and in each case independently
of one another are H, OH, O-formyl, O-acetyl,

O-benzoyl, methoxymethoxy or tetrahydropyranyloxy,
X
is a covalent bond or one of the following bridge
groups 


G2
is a radical of the formula IV


in which

V
is -O-,

W
is H and
Z
is


where m = 1 to 3, n = zero or 1 and o = zero, 1 or
2 and

R(6) to R(9) have the meaning given above under R(2) to
R(5). 
A medicament comprising one or more tetrazole-bile
acid derivatives as claimed in claim 1 or 2.
The use of a compound of the formula I as claimed
in claim 1 or 2 for the preparation of a medicament for

treatment of disturbances in cholesterol metabolism.
The use of a compound of the formula I as claimed
in claim 1 or 2 for the preparation of a medicament for

treatment of hyperlipidaemia.
</CLAIMS>
</TEXT>
</DOC>
